Similar Items: Successful Treatment of Anti-Jo-1 Positive Inflammatory Myopathy With Tofacitinib
- Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Comparison of Rule‐Based Algorithms to Identify Patients With Idiopathic Inflammatory Myopathies in Electronic Health Records
- Assessing the diagnostic utility of baseline creatine kinase levels in patients with suspected idiopathic inflammatory myopathies and neuromuscular disorders
- Clinical Characteristics and Malignancy Prevalence in Idiopathic Inflammatory Myopathies: A Single-Center Study from Southwestern Saudi Arabia
- Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL Study
- Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis